Injectable immunotherapy shrinks precancerous oral lesions in clinical trial
Summary
Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to reduction in lesion size and allowed some patients to avoid surgery, according to re...
Description
Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to reduction in lesion size and allowed some patients to avoid surgery, according to re...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source